Drugs / Novolin 70/30
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01358435 Comparator | Jan → May 2011 | diabetes mellitus | Wockhardt | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Novolin 70/30 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01358435 ↗ |
| Modality | Protein / enzyme biologic | “Novolin 70/30 is a Recombinant Human Insulin” NCT01358435 ↗ |
| Route | Subcutaneous | “given Subcutaneously” NCT01358435 ↗ |